SUBCLINICAL AND CLINICAL EATING DISORDERS IN IDDM NEGATIVELY AFFECT METABOLIC CONTROL

Citation
Sg. Affenito et al., SUBCLINICAL AND CLINICAL EATING DISORDERS IN IDDM NEGATIVELY AFFECT METABOLIC CONTROL, Diabetes care, 20(2), 1997, pp. 182-184
Citations number
20
Categorie Soggetti
Endocrynology & Metabolism
Journal title
ISSN journal
01495992
Volume
20
Issue
2
Year of publication
1997
Pages
182 - 184
Database
ISI
SICI code
0149-5992(1997)20:2<182:SACEDI>2.0.ZU;2-2
Abstract
OBJECTIVE - To characterize the relationship of subclinical and clinic al eating disorders to HbA(1c) values in women with IDDM. RESEARCH DES IGN AND METHODS - Ninety women with IDDM (18-46 years of age) were rec ruited from diabetes clinics throughout Connecticut and Massachusetts. Subjects were categorized into one of three groups according to the D iagnostic Statistical Manual of Mental Disorders (DSM-III-R) criteria for eating disorders as Follows: the clinical group (n = 14), the subc linical group (partially fulfilling the diagnostic criteria; n = 13), and the control group (n = 63). Group differences in the degree of die tary restraint, binge eating, and bulimic behaviors and weight, shape, and eating concerns were assessed with the Eating Disorder Examinatio n (EDE) and the Bulimia Test Revised (BULIT-R). RESULTS - Women with s ubclinical and clinical eating disorders had clinically elevated HbA(1 c) results and more diabetes-related complications, compared with the control subjects, The severity of bulimic behaviors, weight concerns, reduced BMI, and decreased frequency of blood glucose monitoring were associated with elevated HbA(1c). CONCLUSIONS - HbA(1c) may have clini cal utility in the identification of eating disorder behavior in femal es with IDDM. Health care professionals should be aware of the potent effect of subclinical and clinical eating behaviors including insulin misuse in weight-conscious women with IDDM who have poor glycemic cont rol.